Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial

IntroductionImmune checkpoint inhibitors (ICIs) have significantly improved the overall survival for patients with different solid tumors. However, there is an urgent need for predictive biomarkers to identify patients with metastatic melanoma who do not benefit from treatment with ICIs, to prevent...

Full description

Saved in:
Bibliographic Details
Main Authors: Brigit van Dijk, Ivonne J. H. Schoenaker, Astrid A. M. van der Veldt, Jan Willem B. de Groot
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1564463/full
Tags: Add Tag
No Tags, Be the first to tag this record!